Evidence map›Paper›PMID 34575252›Full record

ArticleJournal of clinical medicine2021

Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia.

Sara Bülow Anderberg, Miklos Lipcsey, Michael Hultström, Ann-Katrin Eriksson, Per Venge, Robert Frithiof, On Behalf Of The Uppsala Intensive Care Covid-Research Group

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04316884 (Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04316884 completednot on this map

Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19

TypeobservationalSponsorUppsala UniversityRan2020 to 2025Enrolled380ConditionsCOVID-19, Organ Dysfunction Syndrome Sepsis, Organ Dysfunction Syndrome, Multiple, Septic Shock
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sara Bülow AnderbergDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.
Miklos LipcseyDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.
Michael HultströmDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-4675-1099
Ann-Katrin ErikssonDiagnostics Development a P&M Venge Company, SE-753 12 Uppsala, Sweden.
Per VengeDiagnostics Development a P&M Venge Company, SE-753 12 Uppsala, Sweden.
Robert FrithiofDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-2278-7951
On Behalf Of The Uppsala Intensive Care Covid-Research Group
Uppsala University · SE

Funding

Hjärt-Lungfonden 20210089Science for Life Laboratory KAW 2020.0182Science for Life Laboratory KAW 2020.0241Svensk Njurmedicinsk Förening F2020-398 0054Vetenskapsrådet 2014-02569Vetenskapsrådet 2014-07606
6 · The paper itself

Abstract

Neutrophils have been suggested mediators of organ dysfunction in COVID-19. The current study investigated if systemic neutrophil activity, estimated by human neutrophil lipocalin (HNL) concentration in peripheral blood, is associated with acute kidney injury (AKI) development. A total of 103 adult patients admitted to intensive care, with PCR-confirmed SARS-CoV-2 infection, were prospectively included (Clinical Trials ID: NCT04316884). HNL was analyzed in plasma (P-HNL Dimer) and in whole blood (B-HNL). The latter after ex vivo activation with N-formyl-methionine-leucine-phenylalanine. All patients developed respiratory dysfunction and 62 (60%) were treated with invasive ventilation. Sixty-seven patients (65%) developed AKI, 18 (17%) progressed to AKI stage 3, and 14 (14%) were treated with continuous renal replacement therapy (CRRT). P-HNL Dimer was higher in patients with invasive ventilation, vasopressors, AKI, AKI stage 3, dialysis, and 30-day mortality (

Indexed as

acute kidney injuryCOVID-19HNLintensive careneutrophils

Identifiers

PMID34575252
PMCPMC8464787
OpenAlexW3200823051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.